公司的上述问题导致相关年度报告财务信息披露不准确，违反了《上市公司信息披露管理办法》（证监会令第182号）第三条的规定。翟辉 作为公司董事长及总裁，张林作为公司财务总监，违反了《上市公司信息披露管理办法》（证监会令第182号）第四条的规定，并对公司相 关违规行为负有主要责任。 根据《上市公司信息披露管理办法》（证监会令第182号）五十二条的规定，北京证监局决定对其采取出具警示函的行政监管措施，并记入 证券期货市场诚信档案。 对此，已代理众多股票索赔、获赔的江苏胜衡律师事务所主任宋联民向雷达财经表示，根据证券法及相关规定，上市公司不当行为给投资 者造成损失的，受损投资者可依法索赔。凡是在上市后到2025年11月28日之间买入，并且在2025年11月28日收盘时持有华软科技股票的受 损投资者，可通过公号"雷助吧"（雷助码：99）报名，免费参与索赔。获赔前无任何费用。 雷达财经注意到，6月27日，华软科技发布《关于为控股子公司提供担保的进展公告》。 近日，公司与苏州银行股份有限公司吴中支行（债权人）签署了《最高额保证合同》，同意为债权人按主合同与债务人苏海汇融形成的债 权提供最高额保证担保。担保的主债权为从2025 ...

2024年11月6日，世纪华通公告收到证监会《行政处罚决定书》，经查明，世纪华通违法事实如下： 登录新浪财经APP 搜索【信披】查看更多考评等级 2025年12月18日，上海久诚律师事务所股票索赔律师许峰律师代理的际华集团（维权）（601718）投资 者索赔案再向法院提交一次立案，此前已多次提交立案，目前正在等待法院的下一步安排。律师团队还 在继续推进后续案件的立案工作，还在继续接受其他投资者的索赔委托。（许峰律师专栏） 2025年8月8日晚，际华集团公告于2025年8月8日收到证监会下发的《立案告知书》，因公司涉嫌信息披 露违法违规，根据《证券法》《行政处罚法》等法律法规，证监会决定对公司立案。 许峰律师认为，在2025年8月9日之前买入际华集团股票，并在2025年8月9日后卖出或继续持有股票的投 资者，目前还可发起索赔。（际华集团维权入口） 除了际华集团投资者索赔案再次提交法院立案2025年12月23日，许峰律师代理的部分世纪华通（维权） （002602）投资者索赔案再次提交绍兴市中级人民法院立案，律师团队同步也还在持续接受其他投资者 的索赔委托。需要特别提示的是，许峰律师代理的前期部分世纪华通投资者索赔 ...

Core Viewpoint - The article discusses the ongoing legal actions against Zhiyun Co., Ltd. (智云股份) regarding false statements made to investors, highlighting the potential for investor compensation through legal claims [1][2][3]. Group 1: Legal Proceedings - Zhiyun Co., Ltd. is facing a lawsuit for false statements, with the Shanghai Jucheng Law Firm submitting a case to the Dalian Intermediate People's Court [1][2]. - The law firm is currently accepting claims from other investors who have suffered losses due to the company's actions [1][3]. Group 2: Financial Misconduct - In 2020, Zhiyun Co., Ltd. acquired 81.3181% of Shenzhen Jiutian Zhongchuang Automation Equipment Co., Ltd., which became a subsidiary included in Zhiyun's consolidated financial statements [3][4]. - In 2022, Jiutian Zhongchuang falsely recognized sales revenue of 59.7345 million yuan and profit of 24.1123 million yuan, accounting for 13.27% and 7.09% of Zhiyun's total reported revenue and profit, respectively [4]. - The fraudulent revenue recognition involved a circular flow of funds among Jiutian Zhongchuang, three suppliers, and Jiangxi Mizhan Technology Co., Ltd., with no corresponding real sales activity [4]. Group 3: Investor Compensation Eligibility - Investors who purchased Zhiyun Co., Ltd. shares between April 28, 2023, and April 13, 2024, and sold or continued to hold the shares after April 13, 2024, are eligible to file for compensation [2][5]. - The law firm has a history of successfully representing investors in similar cases, with no fees charged to investors who do not receive compensation [5].

受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 31，292万元，占公司当期净资产的比例分别为12.5%、9.47%；2022年发生额68，800万元，余额35， 543万元，占公司当期净资产的比例分别为20.67%、10.68%。截至2023年4月30日，案涉占用资金已全 部归还。 上述情况，海越能源未按规定及时披露，亦未在2021年半年度报告、2021年年度报告、2022年半年度报 告中披露，在2022年年度报告中部分披露，但未真实、准确、完整披露。 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 上海久诚律师事务所股票索赔律师许峰代理的海越能源（600387）虚假陈述投资者索赔案再出现进展， 2025年12月16日，许峰律师代理的海越能源投资者索赔案再收到绍兴中院调解书，投资者调解获赔。 （许峰律师专栏） 律师团队同步还在继续推进后续案件的立案工作，还在继续接受其他投资者的索赔委托。此前已有部分 案件收到民事调解书，部分投资者调解获赔，部分案件已经收到赔偿款项。 2025年4月16日， ...

受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 2025年12月，上海久诚律师事务所股票索赔律师许峰代理的鹏都农牧（002505）虚假陈述投资者索赔案 已多次向长沙市中级人民法院提交立案。（许峰律师专栏） 此前许峰律师代理的鹏都农牧投资者索赔案已获得长沙中院立案，律师团队还在继续推进后续案件的立 案工作，还在继续接受其他投资者的索赔委托。 鹏都农牧投资者索赔案已有投资者胜诉先例，如果投资者因鹏都农牧虚假陈述受损，目前还可发起索 赔。 2024年11月22日，鹏都农牧发布于公司及相关责任人收到《行政处罚决定书》的公告，经查明，当事人 存在以下违法事实： 一、鹏都农牧未依法及时披露控股股东非经营性资金占用 上海鹏欣（集团）有限公司（以下简称鹏欣集团）是鹏都农牧的控股股东。2020年-2022年间，鹏都农 牧及其子公司向北京雄特牧业有限公司预付购牛款176，898万元，然后鹏欣集团及其关联方以向北京雄 特借款和预收收购意向金的方式，累计非经营性占用鹏 ...

Core Viewpoint - The article discusses the ongoing legal actions against Honggao Creative (002504) due to financial misconduct, including inflated revenues and profits over several years, and the opportunity for affected investors to file claims for compensation. Group 1: Legal Proceedings - The Shanghai Jiucheng Law Firm, represented by lawyer Xu Feng, has submitted a batch of claims to the Beijing Financial Court for investors of Honggao Creative [1][5] - Investors have already received compensation through court-enforced actions, and the law firm continues to accept claims from other investors, with a deadline of approximately twenty days remaining for filing [1][5] Group 2: Financial Misconduct - Honggao Creative's subsidiary, Beijing Honggao Architectural Decoration Design Engineering Co., Ltd., was found to have inflated revenues and profits through fictitious project contracts and improper accounting practices [2][6] - The company reported inflated revenues and profits for the years 2015 to 2022, with specific figures including: - 2015: Revenue inflated by 10.39 million, profit inflated by 2.63 million [2][6] - 2016: Revenue inflated by 21.68 million, profit inflated by 2.81 million [2][6] - 2017: Revenue inflated by 6.20 million, profit reduced by 2.33 million [2][6] - 2018: Revenue inflated by 8.62 million, profit inflated by 77.81 million [2][6] - 2019: Revenue inflated by 3.81 million, profit inflated by 1.45 million [3][7] - 2020: Revenue inflated by 6.28 million, profit inflated by 1.43 million [3][7] - 2021: Revenue inflated by 4.83 million, profit inflated by 0.25 million [3][7] - 2022: Profit reduced by 11.06 million [4][8] Group 3: Investor Claims - Investors who purchased Honggao Creative shares between April 19, 2016, and January 6, 2023, and sold or held the shares after January 6, 2023, are eligible to file claims for compensation [4][8] - Xu Feng, the lawyer, has a history of successfully representing investors in similar cases, with nearly 200 cases won or settled favorably [4][8]

Core Viewpoint - The article discusses ongoing legal actions against Changjiang Health (002435) due to alleged false statements and failure to disclose significant financial issues, leading to investor claims for compensation [1][6]. Group 1: Allegations of Financial Misconduct - Changjiang Health is accused of failing to timely disclose non-operating fund occupation by related parties, with a total of 655 million yuan involved, which is 1.27% of the company's net assets as of 2020 [2][7]. - The company has not reported the ongoing fund occupation, which had an outstanding balance of 3.558 billion yuan as of April 30, 2024, with significant amounts occupied in various periods, reaching up to 79.01% of net assets in 2022 [2][7]. - There were also failures in accounting for liabilities related to commercial acceptance bills and financing leases, resulting in understated liabilities in multiple financial reports, totaling 758 million yuan to 1.353 billion yuan across different periods [3][8]. Group 2: Disclosure Failures - Changjiang Health allegedly did not disclose a significant guarantee involving a 500 million yuan bank acceptance bill, which was backed by a time deposit and constituted 10.75% of the company's audited net assets for 2022 [4][9]. - The company failed to follow necessary shareholder approval procedures for this guarantee, which is a violation of securities laws requiring timely disclosure of such significant events [4][9]. Group 3: Legal Actions and Investor Claims - Investors who purchased Changjiang Health shares between January 5, 2021, and April 30, 2024, and sold or continued to hold them after April 30, 2024, are eligible to initiate claims for compensation [10].

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 上海久诚律师事务所股票索赔律师许峰律师提示，荣联科技（维权）（002642）虚假陈述引发的投资者 索赔案已经进入最后倒计时，目前该案诉讼时效仅有不到两个月，"过期作废"。 许峰律师代理的荣联科技投资者索赔案已向北京金融法院提交立案，律师团队还在继续推进后续案件的 立案工作，还在继续接受其他投资者的索赔委托。信息显示，该案已有投资者获赔先例。 此前2023年1月31日，荣联科技公告称收到北京证监局警示函。经调查，荣联科技公司于2019年7月4 日、8月1日、8月26日和2021年12月22日以预付款等名义向供应商北京顺联科技有限公司合计转账2， 956万元：于2019年11月12日和2021年12月22日以预付款等名义向供应商北京云栖科技有限公司合计转 账1，542万元；上述款项后续均转入大股东王东辉控制的北京极至科技有限公司账户。上述信息涉及信 息 ...

经查，南方精工2023年6月19日在深圳证券交易所互动易平台上回复投资者有关人形机器人相关业务的 内容不准确，导致公司股价连续多次涨停。在股价异动后，南方精工未及时了解造成交易异常波动的影 响因素，未在6月26日、6月28日发布的股票交易异常波动公告中就公司在互动易平台发布内容进行澄 清，未披露造成股价异常波动的影响因素，信息披露不完整。 登录新浪财经APP 搜索【信披】查看更多考评等级 2025年12月10日，上海久诚律师事务所股票索赔律师许峰代理的南方精工（维权）（002553）虚假陈述 投资者索赔案再有进展，已经收到法院的法律文书，法院确认调解合法有效。（许峰律师专栏） 此前许峰律师代理的南方精工投资者索赔案部分案件已经达成调解，投资者将获赔。律师团队还在继续 推进后续案件的立案工作，还在继续接受其他投资者的索赔委托。 2023年7月10日，南方精工公告收到江苏证监局出具的行政监管措施决定书：《江苏证监局关于对江苏 南方精工股份有限公司、史建伟、史维采取出具警示函措施的决定》。 专门从事股票索赔法律事务的上海久诚律师事务所主任许峰律师认为，根据前期投资者获赔条件，在 2023年6月20日到2023年7月 ...

Core Viewpoint - The article discusses the ongoing legal actions against Kangde Xin (002450) for false statements made in financial reports, highlighting the potential for investor claims and the significant discrepancies in reported financial data from 2015 to 2018 [1][5]. Group 1: False Financial Reporting - From 2015 to 2018, Kangde Xin inflated its reported profits through fictitious sales, purchases, and expenses, resulting in total profit overstatements of CNY 2,242,745,642.37, CNY 2,943,420,778.01, CNY 3,908,205,906.90, and CNY 2,436,193,525.40, which represented 136.22%, 127.85%, 134.19%, and 711.29% of the reported profits for those years respectively [1][5]. - The reported bank balances for Kangde Xin from 2015 to 2018 were also found to be false, with actual year-end balances being zero, while reported balances were CNY 9,571,053,025.20, CNY 14,689,542,575.86, CNY 17,781,374,628.03, and CNY 14,468,363,032.12 [2][6]. Group 2: Disclosure Failures - Kangde Xin failed to timely disclose significant guarantees provided to its controlling shareholder, with guarantees amounting to CNY 1,482,700,000.00, CNY 1,463,050,000.00, and CNY 1,463,050,000.00 for the years 2016 to 2018 [3][7]. - The company did not accurately disclose the use of raised funds in its annual reports, leading to further legal implications for the firm [4][8]. Group 3: Legal Proceedings - The Shanghai Jiucheng Law Firm, represented by lawyer Xu Feng, is actively pursuing claims on behalf of investors affected by Kangde Xin's false statements, with ongoing efforts to file additional cases [1][5]. - Investors who purchased Kangde Xin shares between March 22, 2013, and January 23, 2019, and sold or held them after that date are still eligible to file claims [4][8].